Baxter
Baxter appeases EU regulators in $4B Gambro buyout
Baxter hits 52-week high on earnings beat
Sources say Baxter’s near an agreement with EU regulators in $4B Gambro merger
Baxter aims to soothe E.U. antitrust concerns over $4B Gambro merger
Baxter buys stake in Ocular Therapeutix
Greatbatch raises 2013 guidance on restructuring efforts | Wall Street Beat
Texas medical device maker Greatbatch (NYSE:GB) raised its 2013 per-share earnings guidance as it announced new efforts to reorganize some of its business practices and reduce costs as it shifts from a components and sub-assemblies company to a developer of full medical devices.
Baxter meets expectations with Q1 earnings report
Minnesota aims to lure Baxter, other large players with tax incentives
Minnesota regulators are offering tax incentives in hopes of luring more large corporations to the North Star State, and at least one major medical device and diagnostics player is thinking of taking advantage of the offer.
Baxter alerts on HomeChoice dialysis machines in Canada, Hong Kong
Medtronic leads the list of the top medtech lobbying spenders of 2012
Medical device makers reported nearly $29 million in campaign contributions in 2012, with nearly 40% of that coming from just the top 5 donors.